Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers

Journal of Gastrointestinal Oncology

Robert Zaiden²  Ziad T. Awad⁴  Soon N. Huh¹  Meng W. Ho¹  Bradfors S. Hoppe¹  Romaine C. Nichols Jr¹  Zuofeng Li¹  Bestoun Ahmed²  Richard Y. Lee³ 

[1] Radiation Oncology, University of Florida Proton Therapy Institute, USARadiation Oncology, University of Florida Proton Therapy Institute, USARadiation Oncology, University of Florida Proton Therapy Institute, USA;Medicine, University of Florida College of Medicine, USAMedicine, University of Florida College of Medicine, USAMedicine, University of Florida College of Medicine, USA;Radiation Medicine, Roswell Park Cancer Institute, University at Buffalo, NY, USARadiation Medicine, Roswell Park Cancer Institute, University at Buffalo, NY, USARadiation Medicine, Roswell Park Cancer Institute, University at Buffalo, NY, USA;Surgery, University of Florida College of Medicine, USA Surgery, University of Florida College of Medicine, USA Surgery, University of Florida College of Medicine, USA

关键词: Proton therapy;    pancreatic;    dosimetry;    neoadjuvant radiotherapy;   

DOI  :  10.3978/j.issn.2078-6891.2013.043

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown